Literature DB >> 15508001

Will tomorrow's medicines work for everyone?

Sarah K Tate1, David B Goldstein.   

Abstract

Throughout much of the world, 'race' and 'ethnicity' are key determinants of health. For example, African Americans have, by some estimates, a twofold higher incidence of fatal heart attacks and a 10% higher incidence of cancer than European Americans, and South Asian- or Caribbean-born British are approximately 3.5 times as likely to die as a direct result of diabetes than are British of European ancestry. The health care that people receive also depends on 'race' and 'ethnicity'. African Americans are less likely to receive cancer-screening services and more likely to have late-stage cancer when diagnosed than European Americans. Health disparities such as these are one of the greatest social injustices in the developed world and one of the most important scientific and political challenges.

Entities:  

Keywords:  Genetics and Reproduction; Health Care and Public Health

Mesh:

Substances:

Year:  2004        PMID: 15508001     DOI: 10.1038/ng1437

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  40 in total

1.  A family tree in every gene.

Authors:  Armand Marie Leroi
Journal:  J Genet       Date:  2005-04       Impact factor: 1.166

2.  Racial medicine: here to stay? The success of the International HapMap Project and other initiatives may help to overcome racial profiling in medicine, but old habits die hard.

Authors:  Katrin Weigmann
Journal:  EMBO Rep       Date:  2006-03       Impact factor: 8.807

3.  Pharmacogenetics, pharmacogenomics and ecogenetics.

Authors:  Arno G Motulsky; Ming Qi
Journal:  J Zhejiang Univ Sci B       Date:  2006-02       Impact factor: 3.066

4.  Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.

Authors:  Sherry I Brandt-Rauf; Victoria H Raveis; Nathan F Drummond; Jill A Conte; Sheila M Rothman
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

Review 5.  Public willingness to participate in and public opinions about genetic variation research: a review of the literature.

Authors:  Rene Sterling; Gail E Henderson; Giselle Corbie-Smith
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

6.  The structure of common genetic variation in United States populations.

Authors:  Stephen L Guthery; Benjamin A Salisbury; Manish S Pungliya; J Claiborne Stephens; Michael Bamshad
Journal:  Am J Hum Genet       Date:  2007-10-16       Impact factor: 11.025

Review 7.  From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.

Authors:  Daniel W Nebert; Ge Zhang; Elliot S Vesell
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

8.  Grassroots marketing in a global era: more lessons from BiDil.

Authors:  Britt M Rusert; Charmaine D M Royal
Journal:  J Law Med Ethics       Date:  2011       Impact factor: 1.718

Review 9.  The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Authors:  Lara A Ray; Christina S Barr; Julie A Blendy; David Oslin; David Goldman; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

10.  Evaluating the Role of Genetic Variants on first-line antiepileptic drug response in North India: Significance of SCN1A and GABRA1 Gene Variants in Phenytoin Monotherapy and its Serum Drug Levels.

Authors:  Ruchi Baghel; Sandeep Grover; Harpreet Kaur; Ajay Jajodia; Chitra Rawat; Ankit Srivastava; Suman Kushwaha; Rachna Agarwal; Sangeeta Sharma; Ritushree Kukreti
Journal:  CNS Neurosci Ther       Date:  2016-06-01       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.